Home >  Critical Care >  Critical Care News >  One in Three Hospitalised...

One in Three Hospitalised Adult Tetanus Patients Die: Meta-Analysis Finds

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-08-06 02:15 GMT   |   Update On 2025-08-06 02:16 GMT
Advertisement

China: A systematic review and meta-analysis published in BMJ Open has highlighted the alarming mortality rate among hospitalised adult patients with tetanus and identified key factors that significantly influence survival outcomes.

The study, conducted by Zhenlin Chen and colleagues from the Department of Emergency, Zhangzhou Affiliated Hospital of Fujian Medical University, analysed data from 22 observational studies comprising 1,618 adult patients admitted with tetanus between January 2000 and February 2024.

The study revealed the following findings:

  • The pooled analysis showed an overall mortality rate of 32% among hospitalised adult tetanus patients, highlighting the persistent threat of this preventable disease despite medical advancements.
  • The findings emphasize the need for enhanced preventive strategies, including better adult vaccination coverage and timely wound care education, particularly for individuals over 40 years of age.
  • Age ≥40 years was identified as a significant risk factor for mortality (RR = 1.89).
  • An incubation period of less than seven days was linked to higher mortality risk (RR = 2.10).
  • The onset of symptoms within two days increased the likelihood of death (RR = 2.06).
  • Severe disease, indicated by the Ablett classification ≥III, was strongly associated with mortality (RR = 3.40).
  • The presence of autonomic dysfunction was a major predictor of poor outcomes (RR = 4.84).
  • The need for mechanical ventilation significantly increased the mortality risk (RR = 2.46).
  • These identified factors can help clinicians in early risk assessment and implementing targeted management strategies to improve survival in hospitalised tetanus patients.
Advertisement

According to the authors, the meta-analysis is the first of its kind to systematically evaluate mortality and associated risk factors in hospitalised adults with tetanus. Data were extracted independently by two reviewers from four major databases—PubMed, Web of Science, The Cochrane Library, and Embase. Statistical heterogeneity was assessed using the I² statistic, with subgroup and meta-regression analyses performed to explore potential sources of variation among the studies.

While the study provides valuable insights, the authors acknowledged certain limitations. Only four databases were searched, which may have resulted in the exclusion of relevant studies. Additionally, both univariate and multivariate analyses were considered for risk factor extraction, and the small sample size for certain variables may have affected the robustness of the results. Differences in statistical methodologies across studies were also noted as a factor warranting cautious interpretation.

Despite these constraints, the findings carry significant clinical and public health implications. The high mortality rate reinforces the urgent need to strengthen tetanus control measures, particularly focusing on adult immunisation and early intervention for high-risk patients. The identification of specific risk factors provides a framework for targeted care, potentially reducing fatalities in hospitalised cases.

The researchers stress that further large-scale, multicentre prospective studies are necessary to validate these findings and provide more detailed clinical insights. Until then, prioritising vaccination coverage, improving awareness of wound care, and promptly identifying patients at elevated risk could serve as key strategies in reducing tetanus-related deaths among adults.

Reference:

Chen Z, Lin Z, Zhang W, et alMortality and risk factors in hospitalised adult patients with tetanus: a systematic review and meta-analysis. BMJ Open 2025;15:e101782. doi: 10.1136/bmjopen-2025-101782


Tags:    
Article Source : BMJ Open

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal
Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

22 Percent of Indian Children with Diabetic Ketoacidosis Develop Kidney Injury, Reveals Hospital-Based Study

Propofol Meets Esketamine: A Game-Changer for GA in Acute Cesarean Sections, states study

Ampicillin-Sulbactam Outperforms Third-Generation Cephalosporins in Aspiration Pneumonia Outcomes: Study Finds

Indian Review Stresses Prevention Strategies, Early Referral, and Timely Liver Transplantation in Pediatric Acute Liver Failure

Point-of-care ultrasonography found to be effective in identifying pneumothorax: Study

Longer Antibiotic Therapy and Early PCN Drainage Linked to Better Outcomes in Urosepsis with Upper Ureteral Stones: Study

Multidose Ondansetron Reduces Gastroenteritis Severity in Children After ED Visit: New Study Finds